Patient-reported physical functioning predicts the success of hematopoietic cell transplantation (BMT CTN 0902).

TitlePatient-reported physical functioning predicts the success of hematopoietic cell transplantation (BMT CTN 0902).
Publication TypeJournal Article
Year of Publication2016
AuthorsWood, WA, Le-Rademacher, J, Syrjala, KL, Jim, H, Jacobsen, PB, Knight, JM, Abidi, MH, Wingard, JR, Majhail, NS, Geller, NL, J Rizzo, D, Fei, M, Wu, J, Horowitz, MM, Lee, SJ
JournalCancer
Volume122
Issue1
Pagination91-8
Date Published2016 Jan 01
ISSN1097-0142
KeywordsAdult, Aged, Female, Hematologic Neoplasms, Hematopoietic Stem Cell Transplantation, Humans, Male, Middle Aged, Physical Fitness, Quality of Life, Risk Adjustment, Self Report, Surveys and Questionnaires, Transplantation Conditioning, Transplantation, Homologous, Treatment Outcome
Abstract

BACKGROUND: In hematopoietic cell transplantation (HCT), current risk adjustment strategies are based on clinical and disease-related variables. Although patient-reported outcomes (PROs) predict mortality in multiple cancers, they have been less well studied within HCT. Improvements in risk adjustment strategies in HCT would inform patient selection, patient counseling, and quality reporting. The objective of the current study was to determine whether pre-HCT PROs, in particular physical health, predict survival among patients undergoing autologous or allogeneic transplantation.

METHODS: In this secondary analysis, the authors studied pre-HCT PROs that were reported by 336 allogeneic and 310 autologous HCT recipients enrolled in the Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 0902 protocol, a study with broad representation of patients who underwent transplantation in the United States.

RESULTS: Among allogeneic HCT recipients, the pre-HCT Medical Outcomes Study Short Form-36 Health Survey (SF-36) physical component summary (PCS) scale independently predicted overall mortality (hazards ratio, 1.40 per 10-point decrease; P<.001 and="" performed="" at="" least="" as="" well="" currently="" used="" non-pro="" risk="" indices.="" survival="" probability="" estimates="" year="" for="" the="" first="" second="" third="" fourth="" quartiles="" of="" baseline="" pcs="" were="" respectively.="" early="" post-hct="" decreases="" in="" associated="" with="" higher="" overall="" treatment-related="" mortality.="" when="" adjusted="" patient="" variables="" included="" us="" stem="" cell="" therapeutic="" outcomes="" database="" model="" transplant="" center-specific="" reporting="" sf-36="" retained="" independent="" prognostic="" value.="">

CONCLUSIONS: PROs have the potential to improve prognostication in HCT. The authors recommend the routine collection of PROs before HCT, and consideration of the incorporation of PROs into risk adjustment for quality reporting.

DOI10.1002/cncr.29717
Alternate JournalCancer
PubMed ID26439325
PubMed Central IDPMC4707096
Grant ListU10 HL069294 / HL / NHLBI NIH HHS / United States
U01 HL069246 / HL / NHLBI NIH HHS / United States
U24 CA076518 / CA / NCI NIH HHS / United States
U10 HL069301 / HL / NHLBI NIH HHS / United States
P30 CA016086 / CA / NCI NIH HHS / United States
L30 HL114578 / HL / NHLBI NIH HHS / United States
U10 HL069310 / HL / NHLBI NIH HHS / United States
U10 HL109137 / HL / NHLBI NIH HHS / United States
U10HL069294 / HL / NHLBI NIH HHS / United States
U10 HL069246 / HL / NHLBI NIH HHS / United States
U10 HL108987 / HL / NHLBI NIH HHS / United States
R01 CA160684 / CA / NCI NIH HHS / United States